German Biotechnology Days
2025-04-09 08:00 - 2025-04-10 20:00 (Europe/Brussels)
DBT will take place on April 9th ​​and 10th in Heidelberg. The event is considered the German forum for the biotechnology industry, where entrepreneurs exchange ideas with scientists and partners from politics, investors, funding institutions and administration. The two-day program highlights the diverse fields of application and the potential of biotechnology, from health research to the bioeconomy.

The DBT 2025 offers:

a good mix of lectures, panel discussions and breakout sessions,

more than 900 participants,

the largest and most diverse industrial exhibition to date,

a partnering platform for targeted dating and exchange,

evening networking receptions and

above all, plenty of time to get to know each other, exchange ideas and be inspired.

More Info Here

Securing Europe’s biotech future - How can biosecurity drive competitiveness?
2025-04-09 12:00 - 14:00
Biotechnology involves the use of biological systems, organisms, or their components to develop products and solutions across industries such as healthcare, agriculture, and manufacturing. In Europe, it plays an important role in advancing medicine, sustainability, and economic growth. Europe accounts for approximately 12% of the global biotech market, and discussions continue on how to maintain competitiveness in a rapidly evolving sector. Biosecurity ensures biotech technologies are used safely by managing risks and maintaining safety standards.

Often viewed in the context of risk management and regulation, it can be overlooked that biosecurity can also play an important role in innovation and market leadership. Biosecurity approaches can affect trust in biotech products, their attractiveness to investors, the scalability of new technologies, and Europe’s position in shaping global standards. As synthetic biology and advanced biomanufacturing tools develop, discussions on biosecurity frameworks and their impact on investment, trade, and competitiveness are ongoing.

Finding a balance between biosecurity measures and innovation remains a consideration for policymakers and industry stakeholders. At the same time, Europe’s role in shaping global biosecurity standards is seen as a valuable exercise in its broader economic and security strategy.

Join this Euractiv Stakeholder Workshop with our Director General Dr Claire Skentelbery to explore how biosecurity can be a strategic enabler of Europe’s biotech future. Questions to be discussed include:

How can biosecurity strengthen Europe’s competitiveness in biotech?

How can the EU develop a biosecurity approach that supports industrial growth and innovation?

What role can Europe play in shaping global biosecurity standards while maintaining its leadership in biotech?

More Info & Registration Here

Swiss Biotech Days
2025-05-05 08:00 - 2025-05-06 20:00
Since 2021, the Swiss Biotech Day has grown 40% every year and has become a premier global biotechnology conference for life sciences professionals, fostering international collaboration and impactful partnerships. In 2024 it attracted some 2,500 participants from more than 40 countries, including 17 international delegations.Join the Swiss Biotech Day to network, exchange ideas and explore advances in R&D, manufacturing, data management, AI and innovative financing. In addition, the embedded Global Village provides international delegations a platform to strengthen their ties with the Swiss biotech hub to promote cross-border investments, public-private partnerships, R&D collaborations and the exchange of best practices.

More Info Here

Knowledge for Growth 2025
2025-05-07 00:00 - 2025-05-08 23:59
Mark your calendar for Knowledge for Growth 2025, Europe’s premier life sciences conference, taking place on 8 May 2025 in the dynamic city of Antwerp, Belgium!

Connect with over 1,000 life sciences professionals from 500+ companies and organisations, including decision-makers from biotech, pharma, MedTech, AgTech, and healthtech, as well as investors, universities, research institutes, policymakers, and service providers.

Immerse yourself in an action-packed programme offering exclusive insights into the global and regional life sciences landscape, one-to-one partnering, a vibrant trade fair, and countless networking opportunities.

Don’t miss the chance to elevate your knowledge and expand your network at Knowledge for Growth 2025!

USE CODE: KFG2025CLUSTER15 FOR A 15% DISCOUNT

More Info Here

Patient BioForum 2025
2025-05-13 16:00 - 18:00
The theme of the Patient BioForum 2025 is From discovery to access: towards a patient-centric health European ecosystem.

The event is hosted by MEP András Tivadar Kulja, who will hold a keynote speech, and concluding remarks will be given by MEP Stine Bosse.

The panel discussion is moderated by Dr. Nicholas Whyte (Senior Director – APCO) and includes:

Rosa Castro (Public Affairs Director, EURORDIS),

Leire Solis, (Health Policy and Advocacy Director, IPOPI),

Solène Jouan (Policy Officer, European Patients’ Forum),

Irene de Cara Torres (Head of Policy and Government Affairs International, CSL Behring),

Dr. Claire Skentelbery (Director General, EuropaBio),

Rainer Becker (Director SANTE.D Medical Products and Innovation).

The event gathers patients organisations, industry leaders and representatives of EU institutions to discuss how the regulatory framework and future legislations (General Pharmaceutical Legislation, EU Biotech Act and Critical Medicines Act) will support innovation, availability, and access to medicines for EU patients.

EuropaBio’s Patient BioForum aims to facilitate the exchange of views and expertise on scientific, regulatory, and policy issues between patient organisations, the biopharmaceutical industry and policy makers.

For more information, please contact Beatrice Rocco: b.rocco@europabio.org

Registrations for people that do not have a badge to access the European Parliament will close at 12:00 on 6 May 2025. People that have a badge can register beyond this date.

Register Here

LifeScience4EU Conference 2025
2025-05-15 08:00 - 2025-05-16 20:00
Healthcare innovation is a complex, interconnected ecosystem that demands collaboration across research, industry, policy, and patient care. To navigate this landscape effectively, a systems-thinking approach is essential.

LifeScience4EU Conference 2025, held under the Polish Presidency of the Council of the European Union, will bring together top experts to explore how biotechnology, digital health, and next-generation medical technologies can drive meaningful change. By aligning innovation with policy and regulation, the conference aims to build a more resilient and competitive European healthcare sector.

More Info Here

EFIB Brussels Statement – a competitive future for the EU
2025-06-12 13:30 - 14:30
The EFIB Brussels statement was published following the successful workshop that EuropaBio organised together with Genopole during the Bioket conference on 11 March. It looks ahead to the decisions that the EU must now take through the policies and initiatives currently in process. A key opportunity exists for societal and industrial transformation within the sustainability and safety ambitions that make Europe a global figurehead.

The agenda of the EFIB webinar 2025 is as follows:

Presentation of the EFIB statement by our Director General, Claire Skentelbery.

Panel discussion with our wonderful participants.

Confirmed Speakers

Maarit Nyman – Senior Expert on Industrial Bioeconomy, European Commission

Ana Maria Bravo – Director of Government Affairs, IFF

Saskia Kliphuis-Schotsman – Public Affairs Manager, Corbion

Monica Christensen – Senior Public Affairs Manager, Novonesis

This will be followed by a short Q&A session.

Register Here

BIO Convention 2025 - Panel: The EU Policy Evolution and Revolution for Biotech
2025-06-18 09:00 - 10:00
Join EuropaBio in Boston for the key EU policy panel taking place at BIO 2025.

The EU is reshaping its biotechnology landscape, with the focus on competitiveness, supply and capacity resilience and societal benefit. A European Commission 5 year mandate has over 20 legislations and initiatives relevant to biotech and is an opportunity to both anchor and grow European innovation and create an attractive ecosystem for investment for global partners.

Speakers from across the European Commission will address the legislations that are the cornerstone of biotechnology performance, including the EU Biotech Act, General Pharmaceutical Legislation, Critical Medicines Act and others. These legislations aim to accelerate the growth of biotech to market and are underpinned by innovative funding models for industry from institutions such as the European Innovation Council.

Join the panel to find out how major legislative actions support innovation in the European Union and connect to the European Commission.

Moderator:

Claire Skentelbery, Director General EuropaBio

Speakers:

Carmen Laplaza Santos, Head of Unit Health Innovations and Ecosystems, DG RTD, European Commission

Giulia Del Brenna – Head of Unit – DG GROW, European Commission

Thomas Van Cangh – Deputy Head of Unit, DG Sante, European Commission

Denisa Perrin– Head of Unit, EIC Accelerator, European Innovation Council

More Info Here

Spinoff Bulgaria
2025-06-19 08:00 - 2025-06-20 20:00
Spinoff Bulgaria is the largest initiative dedicated to technology transfer, science-based innovation and spinoff investments in Bulgaria and the region. The two-days format includes a wide range of keynotes, panel discussions, workshops and roundtables and offers opportunities for networking, matchmaking and the exchange of best practices.

The target group are scientists, universities and TTOs as well as investors, representatives of national ministries and European organizations, experts, students, innovators and representatives of corporations and business.

More Info Here

Nordic Rare Disease Roadmap Launch at the European Parliament
2025-07-01 15:00 - 17:00
Join us at the European Parliament on Tuesday 1 July, from 15:00 to 17:00. Members of the European Parliament Stine Bosse (Renew Europe, Denmark) and Maria Guzenina (Socialists and Democrats, Finland) are hosting the event, which coincides with Denmark assuming the Presidency of the Council of the European Union. This European Parliament event will bring together key stakeholders to mark an important step forward in our shared work to drive action for the more than 1 million people living with rare diseases in the Nordics and more than 30 million people living with rare diseases in Europe!

Our Director General Dr Claire Skentelbery will be speaking on the panel Rare diseases in the EU agenda: A call for a collective response.

This event is supported by the Nordic Rare Disease group – namely EURORDIS, SBONN, Sjældne Diagnoser, Novo Nordisk, Takeda, Alexion, Sobi, UCB, EFPIA, EuropaBio, and EUCOPE.

Register Here

Advanced Therapies Europe 2025
2025-09-02 08:00 - 2025-09-04 20:00
Now in its 5th year, Advanced Therapies Europe 2025 is an intentionally intimate event — limited to just 500 senior-level decision-makers — to ensure every conversation drives outcomes. Held in Barcelona, at the heart of Europe’s fast-growing biotech ecosystem, this is where strategic connections ignite progress and insights lead to action. Whether you’re here to invest, scale, partner, or launch, ATE 2025 gives you the platform to make it happen.

EuropaBio Director General Dr Claire Skentelbery will take the stage in our Opening Plenary to explore the state of the CGT industry and what Europe must do now to secure its global leadership. With U.S. support for scientific innovation under pressure, the time is now for Europe to sharpen its edge in scalability, affordability, and patient access.

More Info Here

Nordic Rare Disease Summit 2025
2025-09-16 08:00 - 2025-09-17 20:00
The scene has already been set, the roadmap for change is in our hands.

Taking place at the heart of Copenhagen on 16 & 17 September, alongside the Danish Presidency of the European Union, the 2025 Nordic Rare Disease Summit will gather the leading experts within academia and healthcare professionals, patients, decision-makers and industry to discuss solutions; with the joint aspiration of improving the quality of life for people living with rare diseases.

Building on prior summits in 2021 and 2023, the 2025 summit ‘pushing boundaries for rare’ will centre patient empowerment as a key theme.

The expertise of people living with a rare disease must be acknowledged as a resource from the level of individual patients to that of the community, and as a foundation for policymaking in the Nordics and the European Union. Together we can do more.

More Info Here

Life Sciences Baltics 2025
2025-09-17 08:00 - 2025-09-18 20:00
Join our Director General Claire Skentelbery at the Life Sciences Baltics 2025 conference where she will be speaking on The EU Biotech Act – leading Europe’s evolution and revolution for competitiveness.

Life Sciences Baltics is the leading event in the Baltic region, connecting global life sciences professionals. This event provides unique opportunities for project initiation, lead generation, and strategic partnerships through an extensive exhibitor showcase, insightful conferences, a dedicated partnering area, diverse networking formats, and competitions, including a startup pitch challenge.

More Info Here

BIOSPAIN 2025
2025-10-07 08:00 - 2025-10-09 20:00
BioSpain returns to Barcelona between October 7 and 9, 2025. The benchmark fair for Spanish biotechnology will take place in Pavelló 1 of La Fira.Last year BIOSPAIN was a resounding success by convening more than 2,000 registered attendees representing 1,000 entities, 260 exhibitors from more than 34 countries and coordinating more than 5,000 one-to-one meetings scheduled through the partnering system. More than 60 sessions and roundtables created a vibrant forum for discussion of policy issues and technology trends. In 2025 we expect to reach similar figures.

Find Out More & Register Here

NLS Days 2025
2025-10-13 08:00 - 2025-10-14 20:00
Nordic Life Science Days 2025 will be held, for the first time, in Gotheburg, Sweden on 13-14 October at Svenska Mässan located at Mässans Gata/Korsvägen, 412 94 Göteborg – Tel. +46 31 708 80 72

A welcome arena for business and people

Nordic Life Science Days is the largest Nordic partnering conference dedicated to the life science industry. Since its inception in 2013, the event has nurtured a community of people from the world of life science, and created a unique place to do business.

More Info Here

Biotech & Biomanufacturing Policy Summit
2025-10-15 12:00 - 21:00
EuropaBio is pleased to host its third Summit focused on biotechnology & biomanufacturing.

Biotechnology is a critical technology for Europe. Delivery of innovation into market drives competitiveness, security, supply chain resilience plus societal and environmental goals. Europe must be ambitious and globally aware, with a focus on securing its biotechnology capability within fast changing global geopolitics.

The current Commission has a significant opportunity to set and deliver on the ambition needed. Legislation such as the Biotech Act, plus the frameworks that we create for sectors including health, agri-food and manufacturing.

The half day Summit brings together EuropaBio Members and stakeholders to understand the ambition needed for legislation, how the EU and its Member States can deliver and recognition of global positioning needed.

It is supported by biotech product displays and EU projects, plus evening networking reception. It will be followed by a Summit Statement and public webinar hosted in November.

Agenda:

12:30 Registration and lunch13:15 Welcome and Keynote session Summit keynotes bring Industry, Parliament and Commission perspectives to Europe’s ambition for biotech and biomanufacturing and the policy framework currently in action. Commissioner Olivér Várhelyi – Commissioner for Health and Animal Welfare Markus Staempfli – EuropaBio Chair, Vice President Europe Major Markets & Canada, CSL Behring MEP Stine Bosse – MEP and co-chair EU Alliance of Biotech and Life Sciences14:00 Panel sessions The current legislative cluster impacting biotechnology and biomanufacturing is in focus for our panel discussions. Stakeholders from across industry, policy and member states discuss what Europe’s ambition must be and how individual and aligned legislations can deliver.Panel 1 – Enabling EU markets How policy creates markets for biotech products and enables biomanufacturing processes.Panel 2 – Enhancing access How market pathways are vital for product and process commercial viability, determining speed and scale of access and uptake.Panel 3 – Building the EU ecosystem How knowledge, skills, finance and infrastructure deliver on market potential for Europe.17:50 Pre-reception remarks18:00 Reception20:30 Close

This event will be accessible by invitation only, for more information contact us at: communications@europabio.org and c.skentelbery@europabio.org

World Orphan Drug Congress 2025
2025-10-27 08:00 - 2025-10-29 20:00
The World Orphan Drug Congress Europe is the largest and most established event globally for orphan drugs and rare diseases.

Join over 2,000 attendees, gain insights from 250+ industry leaders, and connect with over 130 exhibitors as we bring together experts across the entire orphan drug lifecycle, discussing areas including regulatory affairs and policy to global pricing and cutting-edge gene therapies.

The attendees represent the most senior individuals across the industry, including leaders in R&D, gene therapy, rare diseases, precision/personalised medicine, genetic disorders, patient advocacy and engagement, associations in ATMPs, investors, regulatory affairs professions, governmental bodies, and more…

Find out more and get your tickets using the link below. Get 20% off with the code: EUBIO20

More Info Here

IHI Brokerage Event 2025
2025-11-04 08:00 - 2025-11-05 20:00
Registration is now open for the IHI Brokerage Event 2025, which will be held in Brussels, Belgium on 4-5 November. The event is a prime opportunity for potential applicants to network and start forming consortia for IHI’s next single-stage call for proposals, which is scheduled for launch in early 2026.

Registration is free but obligatory via the event and networking platform. Note that if you signed up to last year’s brokerage platform, you will receive an e-mail with instructions on how to transfer your profile to the new platform.

The brokerage event has been designed to facilitate networking and the formation of consortia for IHI’s next calls for proposals. Find out about the different features of the event…

More Info Here

Pitch Perfect and Boost the EU Bioeconomy 2025
2025-11-24 08:00 - 2025-11-25 20:00
Pitching, Matchmaking And Networking In The Heart Of Europe!

The ‘Pitch Perfect and Boost the European Bioeconomy’ event is a two day event of intense cross-border and cross-sectoral pitching, matchmaking and networking, with the aim to link industry to innovative (biobased) technologies, innovators to investors and to create new partnerships for the future and the further development of innovative, cross-border and cross-sectoral industrial value chains in the biobased economy.

More Info Here

EUCROF26
2026-02-01 08:00 - 2026-02-03 20:00
Building on the momentum of nearly 350 attendees at EUCROF25, EUCROF26 will once again bring together clinical research professionals from across Europe and beyond. Expect three days of high-impact networking, thought-provoking sessions, and future-focused dialogue designed to accelerate innovation and excellence in our field.

Join our Director General Claire Skentelbery from 1–3 February 2026 as we shape the next chapter of clinical research; together.

More Info Here

Navigating Biotech SME Funding: What's available, How it works, What's next for Europe
2026-03-10 10:00 - 11:00
Europe’s biotech sector continues to face significant financing challenges, especially during growth and scale‑up. As the EU moves forward with the landmark Biotech Act, this webinar explores the funding tools available today, how companies can access them, and what changes are needed to expand investment in European biotech.

The session will provide an overview of current EU public and blended finance options across the development pipeline, explain how the European Investment Bank evaluates and supports biotech projects, and offer first-hand insights from a biotech founder on securing funding from idea to market. It will also examine how upcoming EU initiatives could improve access to capital and attract more private investment.

Speakers include

Felicitas Riedl, Director of Innovation and Competitiveness at the European Investment Bank

Raffael Wohlgensinger, Founder & CEO, Formo

Jessica Martinsson, our moderator and CEO of SwedenBIO, the Swedish Biotech Association

Registration Here

BIO-Europe Spring 2026
2026-03-23 08:00 - 2026-03-25 20:00
EuropaBio is joining BIO-Europe Spring 2026.

BIO-Europe Spring is Europe’s largest springtime biotech partnering event, bringing together over 3,700 leaders and innovators in the life sciences industry. It’s designed for partnering, business development, and licensing opportunities in biotechnology and pharmaceuticals.

More Info Here

Special feature: Biotech Act Part I – Dr Claire Skentelbery, Director General EuropaBio @ BIO-Europe Spring 2026
2026-03-23 16:30 - 18:00
Join our Director General Dr Claire Skentelbery at BIO-Europe Spring on the 23rd of March for an afternoon session dedicated to the EU Biotech Act Part 1.

The EU Biotech Act represents a landmark piece of legislation aimed at positioning Europe as a global leader in biotech. Structured in two parts, the legislative program seeks to drive competitiveness across multiple sectors. Part I of the EU Biotech Act, published in December 2025, focuses on advancing health innovation. Key initiatives include accelerating clinical trials, extending intellectual property protections, launching a robust investment program, and introducing strategic projects designed to achieve critical mass in applied innovation. Part II, set to be unveiled in 2026, will shift the focus toward maximising biomanufacturing across industries, further strengthening Europe’s biotech ecosystem.

This feature session is dedicated to the Biotech Act part, including a Keynote and Fireside Chat.

16:30 Keynote presentation: Dr Claire Skentelbery, Director General EuropaBio

17:00 Fireside chat: Dr Claire Skentelbery in discussion with Dr Tilo Mandry, Lead International Liaison Manager IGES

17:15: Session: Special feature: Biotech Act Part I – What’s in it for me? Industry panel discussionPanelists:– Dr Morgane Rousselot, Founder, Chairwoman and CEO, SeaBeLife Biotech– Dr Ann Belien, Founder & CEO, Rejuvenate Biomed (tbc)– Andreas Prenner, Policy Officer, European Commission– Dr Marjo Puumalainen, International Director, SwedenBIO– Dr Tilo Mandry, Lead International Liaison Manager, IGES (Moderator)

This panel continues the EU Biotech Act Special Feature: We will discuss what the Biotech Act means for biotech companies and Europe as a biotech investment location, and how companies can best adapt to its provisions.

There are many questions about the Biotech Act:– How will industrial clinical research be accelerated and how will this affect the development of innovative therapies?– How will the Biotech Act impact the financing of innovative biotech start-ups?– Can cell and gene therapies now be developed more quickly by companies in the EU and brought to patients more easily?– What does the extension of intellectual property protection mean for biopharmaceutical companies in practice?– Is the Act sufficiently targeted at industry and where are the risk points?– And finally, can the EU compete globally, particularly with the US and China, thanks to the Biotech Act?We will discuss these and many other important aspects with the panelists and the audience.

18:00: Close

More Info Here

The EU Biotech Act: Europe’s ambition for biotechnology
2026-04-14 14:30 - 15:30
Join Director General Sandra Gallina and EuropaBio to explore the EU Biotech Act proposal, published in December 2025.

The webinar explores the Goal of the Act, to boost innovation, support development of biotech products and accelerate time-to-market, making use of industrial enablers and regulatory simplification.

This webinar will introduce the drivers behind the Biotech Act proposal plus its diverse and ambitious mechanisms to boost EU biotech delivery. It will discuss how mechanisms might work and the interlink of the Act with the wider European Legislative landscape, and its legislative pathway into action for the EU.

Webinar delegates will have the opportunity to ask Director General Gallina questions during the event and EuropaBio will publish a summary for all participants.

AGENDA

14h30: Introduction – Dr Claire Skentelbery, Director General EuropaBio

14h40: The Biotech Act in focus – Director General Sandra Gallina, DG Health and Food Safety, European Commission:

Regulatory streamlining and facilitation in health, food and other biotech

Industrial enablers including High Impact Strategic Projects, Boosting innovative biotech & biosimilars, Access to Finance, AI and Data, Biosecurity & Defence

15h10: Discussion and audience Q&A

15h30: Close

Who should attend? If you are active within biotechnology in any sector, you should attend to understand what the Act means for you, how you should be involved and what happens next.

Register below

Registration Here

AseBio Green Innovation Forum
2026-04-20 08:00 - 2026-04-21 20:00
AseBio announces the Green Innovation Forum2026, which will take place in Salamanca on 20–21 April 2026, positioning the city as a meeting point for green biotechnology, bioeconomy and sustainable innovation in Europe.The Green Innovation Forum is designed as a meeting point for business development, bringing together companies, startups, investors, technologycentres and institutions committed to accelerating the green transition through biotechnology. The previous 2024 edition brought together 216 participants, from 123 organisations represented and 195 one-to-one meetings, confirming the growing interest in this specialised forum.For the 2026 edition, the Green Innovation Forum strengthens its positioning by broadening its scope to further integrate the agrifood and foodtech sectors, reflecting their increasing convergence with green biotech, the bioeconomy and sustainable innovation. This evolution responds to the need for cross-sector collaboration to address global challenges.

More Info Here

BioSolutions UK
2026-04-21 08:00 - 20:00
Proud to support BioSolutions UK conference — a new platform bringing together leaders in engineering biology to accelerate growth, collaboration and real-world adoption.

Biosolutions are reshaping food, agriculture, chemicals, materials and biofuels, and we’re excited to back an event championing the innovators driving this transition and strengthening the UK’s position in the global bioeconomy.

Join us on 21 April 2026 in London.

More Info Here

CEBioForum 2026
2026-04-22 08:00 - 2026-04-23 20:00
CEBioForum 2026 is a leading international biotechnology conference bringing together professionals from Central and Eastern Europe and beyond. With over 20 years of tradition, CEBioForum serves as a trusted platform for dialogue, partnership-building, and knowledge exchange across the life sciences ecosystem.

The two-day event will take place in the modern spaces of CIC Warsaw, located in the very center of the city, and will feature a comprehensive program including high-level panel discussions, keynote presentations, startup pitch sessions, an exhibition area, and structured B2B networking supported by a dedicated event app. An evening networking reception and the CEBioForum Awards ceremony will further strengthen opportunities for meaningful connections.

The conference agenda will focus on the most relevant trends and challenges shaping the future of biotechnology and life sciences, including biotech and pharma innovation, medtech, clinical trials, data and AI in healthcare, venture capital and financing in CEE, cross-border collaboration, dual-use technologies, and pathways for scaling European innovations to global markets, particularly the US.

CEBioForum 2026 is the place to discover the dynamic Polish and CEE biotech ecosystem, meet decision-makers, investors, entrepreneurs, and researchers, and explore opportunities for collaboration, investment, and growth in one of Europe’s fastest-developing life science regions.

More Info Here

Made by Cells - Biotech Forum
2026-04-29 08:00 - 20:00
Join our Director General Dr Claire Skentelbery in Finland!

Join us at the Hanaholmen Cultural Center in Espoo Finland for inspiring talks on Pharma & Diagnostics, Food, Pigments and Polymers, alongside valuable networking opportunities with leading biotech innovators and stakeholders. Discover cutting-edge advancements and collaborate to shape the future of biotechnology. The event is organised in collaboration with VTT Technical Research Center of Finland

More Info Here

BioPharmaChem Impact 2026
2026-05-06 08:00 - 20:00
BioPharmaChem 2026 will bring together leading business leaders and experts on many pertinent topics including: realising the potential of the ecosystem, sustainability, digitalisation, the power of partnerships, resilient supply chains, the future of work, EU competitiveness and more.

Delegates will enjoy unmissable networking opportunities to connect with many biopharmaceuticals, pharmaceuticals and chemicals professionals in our bespoke exhibition area.

The Awards Dinner will honour excellence in the BioPharmaChem sector and celebrate the remarkable contributions and innovations that are shaping the future of our industry. This will provide a fitting end to a truly engaging event.

More Info Here

EFGCP Conference 2026
2026-05-12 08:00 - 2026-05-13 20:00
EuropaBio is supporting EFGCP Conference 2026.

Europe is at a defining moment for clinical research. The Clinical Trials Regulation set out a powerful vision: a continent united by transparency, collaboration, and efficient access to innovation. While its implementation brought both progress and pressure, it confirmed something essential—Europe’s commitment to ethics, quality, and patient protection remains unwavering.

National ethical review is a vital strength of Europe’s clinical research landscape. Ethics committees play a key role in ensuring trials uphold human dignity, scientific integrity, and public trust. Their contribution, together with the regulatory authorities’ risk-benefit review, forms the foundation of a credible and high‑quality research ecosystem. By further strengthening the collaborative partnership, Europe can achieve an ethical review process that is both protective and efficiently aligned with the needs of modern clinical research.

Today, national ethical review stands at the centre of the conference discussion. Ethics committees face growing complexity; sponsors navigate longer reviews and more information requests. These challenges highlight not failure, but opportunity: the chance to rethink how Europe aligns ethical excellence with operational efficiency.

In addition, the European Commission’s proposed new Biotech Act offers a fresh pathway—clearer roles, streamlined processes, and modern ethical standards grounded in the 2024 Declaration of Helsinki. It invites us to shape a system worthy of Europe’s innovation leadership ambitions.

The EFGCP Conference 2026 is where this work begins. Here, stakeholders from across Europe come together to share best practice experiences, challenge assumptions, and co‑create practical solutions to optimise the system. Our goal is simple and ambitious: to strengthen participant protection while enabling efficient, faster, more predictable clinical trial authorisations and start up times.

Together, we have the opportunity to build an ethical review model that reflects Europe at its best—responsible, collaborative, transparent and ready to lead the next chapter of global research.

More Info & Registration Here
